Winthrop Advisory Group »

Karyopharm Therapeutics shares owned by Winthrop Advisory Group

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Winthrop Advisory Group from 13F filings

Historical chart of Winthrop Advisory Group investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Winthrop Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Winthrop Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $23k 15k 1.51

More positions owned by Winthrop Advisory Group

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Blackrock Ultra (ICSH)
SPDR Portfolio Total Stock Market ETF Prtflo S&p500 Gw (SPYG)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Extend Mkt Etf (VXF)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Winthrop Advisory Group

Top funds holding Karyopharm Therapeutics

Vanguard Group
Avidity Partners Management
Palo Alto Investors
Citadel Advisors
Marshall Wace
Bnp Paribas Arbitrage, Snc
Millennium Management
CAM Group Holding A/S
Deutsche Bank Aktiengesellschaft
GSA Capital Partners
Goldman Sachs Group
Jpmorgan Chase & Co
AlphaCentric Advisors
Tejara Capital
Barclays

View all funds holding Karyopharm Therapeutics